| ASSET | YEARS | % RETURN |
|---|---|---|
Natwest (NWG) | 2004-2007 | 15,058,300% |
QVC (QVCGA) | 2004-2007 | 9,894,038.89% |
India Globalization Capital (IGC) | 2004-2007 | 9,833,233.33% |
Northern Oil & Gas (NOG) | 2004-2007 | 2,278,907.69% |
National Grid PLC ADR (NGG) | 2004-2007 | 1,604,552.94% |
Know Labs (KNW) | 2004-2007 | 763,220.61% |
Perspective Therapeutics (CATX) | 2004-2007 | 669,900% |
Ring Energy (REI) | 2004-2007 | 263,900% |
Ocean Power Technologies (OPTT) | 2004-2007 | 180,233.33% |
Gulf Resources (GURE) | 2004-2007 | 55,900% |
Gyre Therapeutics (GYRE) | 2004-2007 | 17,414.09% |
Broadwind Energy (BWEN) | 2004-2007 | 17,060.69% |
Universal Insurance (UVE) | 2004-2007 | 16,645.24% |
MAG Silver (MAG) | 2004-2007 | 8,300.17% |
Flotek Industries (FTK) | 2004-2007 | 7,036.63% |
Champions Oncology (CSBR) | 2004-2007 | 6,900% |
NanoViricides (NNVC) | 2004-2007 | 5,360% |
Monster Beverage (MNST) | 2004-2007 | 4,108.44% |
Dmc Global (BOOM) | 2004-2007 | 4,104.7% |
VirnetX (VHC) | 2004-2007 | 3,166.72% |
Insteel Industries (IIIN) | 2004-2007 | 2,985.15% |
Taoping (TAOP) | 2004-2007 | 2,418.52% |
BRF SA ADR (BRFS) | 2004-2007 | 2,107.18% |
NeoGenomics (NEO) | 2004-2007 | 2,060% |
Oramed Pharmaceuticals (ORMP) | 2004-2007 | 2,056.19% |
